Malcolm Stacey, ShareProphets – Tom no likey this medical pioneer. But I do…
Hello Share Rattlers. Quite a few of my friends face a grim Christmas. They are undergoing radio and chemo treatment for cancer. Is it me, or is the number of cases growing even faster than normal? I am invested in a few companies that are fighting this scourge. One such outfit is Feedback (FDBK). This […]
It’s Him, TYM! Mining for Toothpaste and Telescopes and Possibly Worth a Punt – Malcolm Stacey, ShareProphets
Hello Share Swingers. A little miner called Tertiary Minerals (TYM) has graced my modest blog on Shareprophets before now. In the past, it’s been a big winner for me. I well remember being at Tom’s pizza emporium helping to prepared hand-outs for the big 2014 UK investor Show when I spotted on my laptop that […]
Malcolm Stacey’s share tip of the year No 1 – buy Advanced Oncotherapy
Malcolm Stacey’s share tip of the year No 1 – buy Advanced Oncotherapy By Malcolm Stacey | Saturday 26 December 2015 Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I […]
Malcolm Stacey of ShareProphets – My First-Hand Check on Medical Opportunities As I End Up in Hospital. Ref. Feedback, Avacta & Advanced Oncotherapy
Hello Share Folk. I’m going to the hospital today to see about my prostate gland. I started the routine tests a few years ago and have been under the eye of a brilliant consultant ever since. There’s a lot of debate of whether we should have these tests done, as it causes a lot of […]
Malcolm Stacey of ShareProphets – Feedback and the Big Spanish Connection
Hello Share Thrashers. It’s not my custom to return to promising shares I’ve brought to your attention in the recent past. I normally wait at least six months or so – with only a few exceptions. But the story is growing fast for one bio science company that I’ve featured quite recently – Feedback (FDBK). […]
ShareProphets – Feedback Shares Soften, but is that a Buying Opportunity?
By Malcom Stacey at ShareProphets Hello Share Sappers. I beg your indulgence to return to Feedback (FDBK), the company which uses whizzo computers to help diagnose and monitor many types of cancer. As reported previously, this could be a topping investment. Though, as per usual, we should always add a cautionary note about medical pioneers. […]